Navigation Links
Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer
Date:6/22/2009

ed in two different cancer types in Phase III," said Dr. Oliver Kisker, Senior Vice-President, Global Clinical Development Unit Oncology, Merck KGaA.

"We are very pleased by the robust development program our partner, Merck KGaA, is conducting for Stimuvax," said Robert L. Kirkman, M.D., President and Chief Executive Officer of Oncothyreon. "The addition of the Phase 3 STRIDE trial in breast cancer to the Phase 3 START trial in non-small cell lung cancer (NSCLC) is evidence of their strong commitment to this innovative product candidate."

About Stimuvax

Stimuvax is an investigational therapeutic cancer vaccine designed to induce an immune response to cancer cells that express MUC1, a glycoprotein antigen widely expressed on common cancers. MUC1 is over-expressed on many cancers such as lung cancer, breast cancer, prostate cancer and colorectal cancer. Stimuvax is thought to work by stimulating the body's immune system to identify and destroy cancer cells expressing MUC1.

In addition to STRIDE, Merck KGaA currently is conducting a global Phase 3 trial of Stimuvax known as START (Stimulating Targeted Antigenic Responses To NSCLC). START is a randomized, double-blind, placebo-controlled study that will evaluate patients with documented unresectable stage III NSCLC who have had a response or stable disease after at least two cycles of platinum-based chemo-radiotherapy. START is expected to enroll more than 1,300 patients in over 30 countries. For more information on the START trial log on to www.nsclcstudy.com or www.clinicaltrials.gov.

About Oncothyreon

Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted sma
'/>"/>

SOURCE Oncothyreon Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Oncothyreon appoints Scott Peterson as Vice President of Research and Development
2. Oncothyreon announces clinical data from three product candidates presented at American Society of Clinical Oncology (ASCO) Annual Meeting
3. Oncothyreon announces closing of $11.1 million registered direct financing
4. Oncothyreon announces commitments to purchase $11.1 million of company securities in a registered direct financing
5. Oncothyreons PX-866 is effective in preclinical model of pulmonary fibrosis
6. Oncothyreon announces presentations at American Society of Clinical Oncology (ASCO) Annual Meeting
7. Oncothyreon reports first quarter 2009 financial results
8. Oncothyreon regains compliance with NASDAQ listing requirements
9. Oncothyreon to present at Invest Northwest 2009
10. Oncothyreon reports full year and fourth quarter 2008 financial results
11. Oncothyreon announces webcast of fourth quarter and year end 2008 financial results conference call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... The very idea of fibers made of carbon nanotubes is ... literally. , The single-walled carbon nanotubes in new fibers created ... through a process designed by chemist Angel Mart and his ... reported its results this month in the journal ACS ... they,re drawn together into a fiber. , Left to their ...
(Date:9/15/2014)... MORRISVILLE, NC (PRWEB) September 15, 2014 ... newly developed deep imaging OCT system for the optical ... , The EnvisuTM S4410 SDOCT for Contact ... measurements for standard and high complexity contact lens, IOL ... allows imaging of a complete contact lens immersed in ...
(Date:9/15/2014)... BOISE, Idaho , Sept. 15, 2014  iVinci ... and only comprehensive Patient Revenue Management system, branded as ... The company also announced the launch of a new ... Portal that provides an easy and convenient way for ... plans for balances owed by them and their families. ...
(Date:9/15/2014)... The chemistry, taste, and health effects of tea can vary ... the nonprofit American Botanical Council (ABC). Recent research by ... on the phytochemical compounds in tea ( Camellia sinensis ) ... in the Yunnan province of southwestern ... future of medicinal botanicals. Dr. Ahmed,s report on ...
Breaking Biology Technology:Rice rolls 'neat' nanotube fibers 2Rice rolls 'neat' nanotube fibers 3Bioptigen Introduces Deep Imaging OCT System for Contact Lens Metrology 2iVinci Health Raises $5M to Fuel National Expansion, Announces Launch of Personal Finance Portal for Healthcare 2iVinci Health Raises $5M to Fuel National Expansion, Announces Launch of Personal Finance Portal for Healthcare 3Tea Taste and Quality Affected by Climate Change 2Tea Taste and Quality Affected by Climate Change 3Tea Taste and Quality Affected by Climate Change 4
... Switzerland, Jan. 5, 2012   Selexis SA ... Ph.D., will present at the Biotech Showcase 2012 Conference ... Conference in San Francisco, CA. Dr. Fisch ... Growth Investment" to prospective investors and corporate partners on ...
... Calif., Jan. 5, 2012  AtheroNova, (OTCQB: AHRO) ("AtheroNova"), a biotech ... regress atherosclerotic plaque, announced today that it has appointed Johan ... of Directors of the Company effective January 3, 2012. Mr. ... Audit and Medical Committees of the Board. ...
... 2012 CMC Biologics, a leading biopharmaceutical contract ... No. US 2,171,034 B1 covering a method for ... culture bioreactors. The invention is designed to optimize ... fermentation process, wherein the bioreactor (fermenter) has an ...
Cached Biology Technology:Selexis SA to Present at Biotech Showcase 2012 2AtheroNova Announces a New Board Member 2AtheroNova Announces a New Board Member 3CMC Biologics Strengthens its Innovative Biomanufacturing Technology Portfolio in Continuous Perfusion Systems 2
(Date:9/16/2014)... available in Spanish . ... study published in the Journal of Cell Biology ... for proper cell division , At this very moment thousands ... the mechanism by which the body repairs damaged tissues and ... complex process known as "mitosis", during which the cell duplicates ...
(Date:9/16/2014)... PALM BEACH GARDENS, Fla. , Sept. 16, ... provider of biometric identity management solutions, announced today ... handheld solution designed to authenticate the identity of ... The Android-based Verifier Sentry rapidly reads ... the credential holder,s ID by matching the biometric ...
(Date:9/15/2014)... populations may continue to drop in French Guiana, despite ... National de la Chasse et de la Faune Sauvage ... data retrieved from camera traps in the Nouragues National ... data to current harvest rates in the region., "In ... Guiana," said Matthias Tobler, a scientist with the San ...
Breaking Biology News(10 mins):Unraveling cell division 2Unraveling cell division 3Cross Match Launches New Identity Management Handheld Solution 2
... underlying brain skills needed to think, remember and learn are ... fact of life for most older Americans. ... critically important for lessening declines in mental performance as people ... efforts aimed at preventing or delaying cognitive decline, dietary modifications ...
... on biomarkers of cardiovascular disease: implications for heart-healthy diets," ... , examined 26 clinical studies and two meta-analyses to ... Of the probiotics examined, L. reuteri NCIMB 30242 ... (TLC) dietary requirements by: , Significantly ...
... , Fires in and around Snowy River National Park in ... (MODIS) aboard the Aqua satellite on February 06, 2014. Actively ... red. Hot, dry, windy conditions in Victoria have been ... territory. The fires in this image are located in ...
Cached Biology News:Nutritional supplement improves cognitive performance in older adults, study finds 2Nutritional supplement improves cognitive performance in older adults, study finds 3Heart health through gut health 2
Request Info...
Kit containing positive control DNA all parts of the HIV-1 genome, HIV-1 negative control DNA, Primers SK38, SK39, SK19...
Contains 0.2 g/L EDTA4Na in phosphate-buffered saline....
Immunochemistry 1 & 2...
Biology Products: